| Entry |
|
|---|
| Name |
Carteolol hydrochloride (JP16/USP);
Cartrol (TN);
Ocupress (TN)
|
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C16H24N2O3. HCl
|
|---|
| Exact mass |
328.1554
|
|---|
| Mol weight |
328.8343
|
|---|
| Structure |
     |
|---|
| Activity |
Anti-adrenergic [beta-receptor] [DS: H00612]
|
|---|
| Remark |
Therapeutic category: ATC code: |
|---|
| Target |
beta1-adrenergic receptor antagonist [HSA: 153] [KO: K04141]; beta2-adrenergic receptor antagonist [HSA: 154] [KO: K04142]; beta3-adrenergic receptor antagonist [HSA: 155] [KO: K04143] |
|---|
| Pathway |
|
|---|
| Metabolism |
Enzyme: CYP2D6 [HSA: 1565]
|
|---|
| Interaction |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D00599 Carteolol hydrochloride (JP16/USP)
2 Agents affecting individual organs
21 Cardiovascular agents
212 Antiarrhythmic agents
2123 Beta blockers
D00599 Carteolol hydrochloride (JP16/USP)
214 Antihypertensives
2149 Others
D00599 Carteolol hydrochloride (JP16/USP)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS
C07AA Beta blocking agents, non-selective
C07AA15 Carteolol
D00599 Carteolol hydrochloride (JP16/USP)
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01ED Beta blocking agents
S01ED05 Carteolol
D00599 Carteolol hydrochloride (JP16/USP)
USP drug classification [BR:br08302]
Ophthalmic Agents
Ophthalmic Antiglaucoma Agents
Beta-Adrenergic Blocking Agents, Ophthalmic
Carteolol
D00599 Carteolol hydrochloride (JP16/USP)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
beta1-adrenergic receptor [HSA:153] [KO:K04141]
Carteolol [ATC:C07AA15 S01ED05]
D00599 Carteolol hydrochloride (JP16/USP)
beta2-adrenergic receptor [HSA:154] [KO:K04142]
Carteolol [ATC:C07AA15 S01ED05]
D00599 Carteolol hydrochloride (JP16/USP)
beta3-adrenergic receptor [HSA:155] [KO:K04143]
Carteolol [ATC:C07AA15 S01ED05]
D00599 Carteolol hydrochloride (JP16/USP)
 |
|---|
| Other DBs |
CAS: 51781-21-6 PubChem: DrugBank: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 22
1 X Cl 34.1717 -16.9041
2 C1x C 24.1844 -15.2181
3 C5x C 24.1844 -16.6229
4 N1x N 25.4010 -17.3254
5 C8y C 26.6177 -16.6229
6 C8y C 26.6177 -15.2181
7 C1x C 25.4010 -14.5157
8 C8x C 27.8343 -17.3254
9 C8x C 29.0509 -16.6229
10 C8x C 29.0509 -15.2181
11 C8y C 27.8343 -14.5157
12 O5x O 22.9678 -17.3254
13 O2a O 27.8343 -13.1108
14 C1b C 29.0530 -12.4072
15 C1c C 30.2536 -13.1006
16 C1b C 31.4445 -12.4130
17 O1a O 30.2537 -14.5154
18 N1b N 32.6401 -13.1036
19 C1d C 33.8337 -12.4145
20 C1a C 35.0333 -11.7219
21 C1a C 34.5265 -13.6153
22 C1a C 33.1223 -11.1820
BOND 22
1 2 3 1
2 3 4 1
3 4 5 1
4 5 6 1
5 6 7 1
6 2 7 1
7 5 8 2
8 8 9 1
9 9 10 2
10 10 11 1
11 6 11 2
12 3 12 2
13 11 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 15 17 1
18 16 18 1
19 18 19 1
20 19 20 1
21 19 21 1
22 19 22 1
|
|---|
